Johnson & Johnson Submits Guselkumab Application to FDA for Ulcerative Colitits
The submission could grant guselkumab its third indication, after being approved by the FDA for psoriasis and psoriatic arthritis.
Source: hcplive.com
Quasar Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Quasar Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Quasar Study Today - Breaking & Trending Today